Home
»
Supply Chain Management in the Drug Industry
Supply Chain Management in the Drug Industry
Regular price
€109.99
603 verified reviews
100% verified
In stock with our UK publisher. 14-28 days
Delivery/Collection within 10-20 working days
Shipping & Delivery
Our Delivery Time Frames Explained
2-4 Working Days: Available in-stock
14-28 Working Days: On Backorder
Will Deliver When Available: On Pre-Order or Reprinting
We ship your order once all items have arrived at our warehouse and are processed. Need those 2-4 day shipping items sooner? Just place a separate order for them!
Close
supply-chain management and pharmaceutical industry
A01=Hedley Rees
Author_Hedley Rees
building of a patient value stream
capable processes and suppliers
Category=KJMV8
Category=KND
Category=TDCW
chemistry manufacturing controls
cost effective and risk mitigated pharmaceutical supply chains
drug development and supply-chains
effective flow of information
eq_bestseller
eq_business-finance-law
eq_isMigrated=1
eq_nobargain
eq_non-fiction
eq_tech-engineering
flexible plant and equipment
reduced waste
shorter cycle times
streamlined logistics
supply of drug
supply-chains in the pharmaceutical sector
CMC
Product details
- ISBN 9780470555170
- Weight: 780g
- Dimensions: 164 x 241mm
- Publication Date: 11 Feb 2011
- Publisher: John Wiley & Sons Inc
- Publication City/Country: US
- Product Form: Hardback
This book bridges the gap between practitioners of supply-chain management and pharmaceutical industry experts. It aims to help both these groups understand the different worlds they live in and how to jointly contribute to meaningful improvements in supply-chains within the globally important pharmaceutical sector. Scientific and technical staff must work closely with supply-chain practitioners and other relevant parties to help secure responsive, cost effective and risk mitigated supply chains to compete on a world stage. This should not wait until a drug has been registered, but should start as early as possible in the development process and before registration or clinical trials. The author suggests that CMC (chemistry manufacturing controls) drug development must reset the line of sight – from supply of drug to the clinic and gaining a registration, to the building of a patient value stream. Capable processes and suppliers, streamlined logistics, flexible plant and equipment, shorter cycle times, effective flow of information and reduced waste. All these factors can and should be addressed at the CMC development stage.
Hedley Rees runs the independent consulting company Biotech PharmaFlow, which specializes in pharmaceutical supply chain management. He has been actively building, managing, and continuously improving supply chains in biotech for the last fifteen years.
Supply Chain Management in the Drug Industry
€109.99
